NCT07013097View on ClinicalTrials.gov

A Phase I Clinical Trial to Evaluate the Single Dose Ascending and Food Effects of PG-033 in Healthy Adults

PHASE1RecruitingINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

May 23, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

December 31, 2025

Conditions
Lichen Simplex Chronicus
Interventions
DRUG

PG-033

Oral tablets (2mg， 10mg)

DRUG

PG-033 placebo comparator

Oral tablets (2 mg, 10 mg) (matching corresponding study medication)

Trial Locations (1)

100038

RECRUITING

Beijing Shijitan Hospital , Capital Medical University, Beijing

Sponsors
All Listed Sponsors
lead

Prime Gene Therapeutics Co., Ltd.

INDUSTRY

NCT07013097 - A Phase I Clinical Trial to Evaluate the Single Dose Ascending and Food Effects of PG-033 in Healthy Adults | Biotech Hunter | Biotech Hunter